![](/images/graphics-bg.png)
Effect of Intravitreal Ranibizumab in the Treatment of Peripapillary Choroidal Neovascularisation
المؤلفون المشاركون
Hamoudi, Hassan
Sørensen, Torben Lykke
المصدر
العدد
المجلد 2011، العدد 2011 (31 ديسمبر/كانون الأول 2011)، ص ص. 1-4، 4ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2011-12-22
دولة النشر
مصر
عدد الصفحات
4
التخصصات الرئيسية
الملخص EN
Intravitreal ranibizumab therapy is widely used in treatment of subfoveal choroidal neovascularisation (CNV) in age-related macular degeneration.
We wanted to study the effect of intravitreal ranibizumab therapy in peripapillary CNV.
A prospective recording of treatment outcomes in twelve eyes (12 patients) with peripapillary CNV with intravitreal injections of ranibizumab was performed.
The patients received a series of 3 injections 4–6 weeks apart, and then a new ophthalmic examination was made including OCT and further therapy was given if the peripapillary CNV was still active.
Nine patients had idiopathic peripapillary CNV, and in 3 patients it was associated to age-related macular degeneration.
Followup had to be at least 6 months.
The mean follow-up time was 15.9 (range 9–27) months and the mean number of injections 6.2 (3–10).
In 10 patients treatment had resulted in an inactivation of the peripapillary CNV, but 3 of them had reactivation, while 2 patients had no inactivation.
Currently, 5 patients are continuous to receive treatment.
VA improved in 10 patients.
Intravitreal ranibizumab therapy appears to be effective in patients with peripapillary CNV, but in some cases there is repeated reactivation or continuous activity of the peripapillary CNV.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Hamoudi, Hassan& Sørensen, Torben Lykke. 2011. Effect of Intravitreal Ranibizumab in the Treatment of Peripapillary Choroidal Neovascularisation. Journal of Ophthalmology،Vol. 2011, no. 2011, pp.1-4.
https://search.emarefa.net/detail/BIM-484208
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Hamoudi, Hassan& Sørensen, Torben Lykke. Effect of Intravitreal Ranibizumab in the Treatment of Peripapillary Choroidal Neovascularisation. Journal of Ophthalmology No. 2011 (2011), pp.1-4.
https://search.emarefa.net/detail/BIM-484208
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Hamoudi, Hassan& Sørensen, Torben Lykke. Effect of Intravitreal Ranibizumab in the Treatment of Peripapillary Choroidal Neovascularisation. Journal of Ophthalmology. 2011. Vol. 2011, no. 2011, pp.1-4.
https://search.emarefa.net/detail/BIM-484208
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-484208
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)